ID17274A - Senyawa yang aktif secara farmakologi - Google Patents

Senyawa yang aktif secara farmakologi

Info

Publication number
ID17274A
ID17274A IDP962513A ID962513A ID17274A ID 17274 A ID17274 A ID 17274A ID P962513 A IDP962513 A ID P962513A ID 962513 A ID962513 A ID 962513A ID 17274 A ID17274 A ID 17274A
Authority
ID
Indonesia
Prior art keywords
active compound
pharmacological active
pharmacological
compound
active
Prior art date
Application number
IDP962513A
Other languages
English (en)
Indonesian (id)
Inventor
Malcolm Stuart Nobbs
Sandra Jane Rodgers
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ID17274A publication Critical patent/ID17274A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IDP962513A 1995-09-05 1996-09-03 Senyawa yang aktif secara farmakologi ID17274A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9518027.9A GB9518027D0 (en) 1995-09-05 1995-09-05 Pharmacologically active compound

Publications (1)

Publication Number Publication Date
ID17274A true ID17274A (id) 1997-12-18

Family

ID=10780172

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP962513A ID17274A (id) 1995-09-05 1996-09-03 Senyawa yang aktif secara farmakologi

Country Status (32)

Country Link
US (1) US6124308A (cs)
EP (1) EP0879230B1 (cs)
JP (1) JPH11512108A (cs)
KR (1) KR19990044397A (cs)
CN (1) CN1200729A (cs)
AP (1) AP640A (cs)
AR (1) AR004192A1 (cs)
AT (1) ATE203523T1 (cs)
AU (1) AU710091B2 (cs)
BG (1) BG65102B1 (cs)
BR (1) BR9610388A (cs)
CA (1) CA2230362A1 (cs)
CO (1) CO4750651A1 (cs)
CZ (1) CZ65598A3 (cs)
DE (1) DE69614150T2 (cs)
EA (1) EA000695B1 (cs)
ES (1) ES2160834T3 (cs)
GB (1) GB9518027D0 (cs)
HR (1) HRP960399A2 (cs)
HU (1) HUP9901260A3 (cs)
ID (1) ID17274A (cs)
IL (1) IL123414A0 (cs)
IS (1) IS4673A (cs)
NO (1) NO980923L (cs)
NZ (1) NZ318390A (cs)
PL (1) PL325329A1 (cs)
SK (1) SK28598A3 (cs)
TR (1) TR199800386T1 (cs)
TW (1) TW367326B (cs)
WO (1) WO1997009317A2 (cs)
YU (1) YU49796A (cs)
ZA (1) ZA967466B (cs)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR016212A1 (es) * 1998-04-28 2001-06-20 Astra Ab Uso de compuestos farmaceuticos que tienen una actividad antagonista de nmda para preparar un medicamento para el tratamiento del sindrome de intestino irritable (ibs), y composiciones farmaceuticas
EP1085890A1 (en) * 1998-06-08 2001-03-28 Advanced Medicine, Inc. Novel sodium channel drugs and uses
US6420354B1 (en) 1998-06-08 2002-07-16 Advanced Medicine, Inc. Sodium channel drugs and uses
GB9907965D0 (en) * 1999-04-09 1999-06-02 Glaxo Group Ltd Medical use
US6479498B1 (en) 1999-06-04 2002-11-12 Theravance, Inc. Sodium channel drugs and uses
PL365701A1 (en) * 2000-07-21 2005-01-10 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
CA2439468A1 (en) 2001-02-27 2002-09-06 Teva Pharmaceutical Industries Ltd. New crystal forms of lamotrigine and processes for their preparations
EP2316468A1 (en) 2002-02-22 2011-05-04 Shire LLC Delivery system and methods for protecting and administering dextroamphetamine
WO2003090693A2 (en) * 2002-04-23 2003-11-06 Teva Pharmaceutical Industries Ltd. Pharmaceutical composition containing lamotrigine particles of defined morphology
CA2514574A1 (en) * 2003-01-30 2004-08-12 Dynogen Pharmaceuticals, Inc. Use of sodium channel modulators for treating gastrointestinal tract disorders
GB0603087D0 (en) * 2006-02-15 2006-03-29 Glaxo Group Ltd Novel use
US8093268B2 (en) 2007-01-24 2012-01-10 Glaxo Group Limited Pharmaceutical compositions comprising 2-methoxy-5-(5-trifluoromethyl-tetrazol-1-yl-benzyl)-(2S-phenylpiperidin-3S-yl-)
GB201111712D0 (en) 2011-07-08 2011-08-24 Gosforth Ct Holdings Pty Ltd Pharmaceutical compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL124029B1 (en) * 1979-06-01 1982-12-31 Wellcome Found Process for preparing novel derivatives of 1,2,4-triazine
FI895821A7 (fi) * 1988-12-07 1990-06-08 The Wellcome Foundation Ltd Farmaseuttisesti aktivisia CNS-yhdisteitä

Also Published As

Publication number Publication date
DE69614150D1 (de) 2001-08-30
PL325329A1 (en) 1998-07-20
ATE203523T1 (de) 2001-08-15
WO1997009317A3 (en) 1997-04-03
KR19990044397A (ko) 1999-06-25
WO1997009317A2 (en) 1997-03-13
TR199800386T1 (xx) 1998-05-21
ZA967466B (en) 1998-04-06
BG102342A (en) 1998-09-30
EP0879230A2 (en) 1998-11-25
JPH11512108A (ja) 1999-10-19
NO980923D0 (no) 1998-03-04
TW367326B (en) 1999-08-21
IL123414A0 (en) 1998-09-24
CA2230362A1 (en) 1997-03-13
NZ318390A (en) 1999-02-25
EA199800189A1 (ru) 1998-10-29
AU6986596A (en) 1997-03-27
AP640A (en) 1998-04-14
HUP9901260A2 (hu) 1999-09-28
DE69614150T2 (de) 2001-11-22
CZ65598A3 (cs) 1998-07-15
ES2160834T3 (es) 2001-11-16
BG65102B1 (bg) 2007-02-28
US6124308A (en) 2000-09-26
HUP9901260A3 (en) 2001-04-28
IS4673A (is) 1998-02-23
NO980923L (no) 1998-05-04
CO4750651A1 (es) 1999-03-31
EA000695B1 (ru) 2000-02-28
AR004192A1 (es) 1998-11-04
HRP960399A2 (en) 1998-04-30
YU49796A (sh) 1999-07-28
EP0879230B1 (en) 2001-07-25
MX9801680A (es) 1998-05-31
AP9600857A0 (en) 1996-10-31
AU710091B2 (en) 1999-09-16
GB9518027D0 (en) 1995-11-08
SK28598A3 (en) 1998-09-09
BR9610388A (pt) 1999-07-06
CN1200729A (zh) 1998-12-02

Similar Documents

Publication Publication Date Title
ZA968767B (en) Pharmaceutically active compounds
GB9520822D0 (en) Therapeutically active compounds
IT1277331B1 (it) Seggiolone a chiusura migliorata
NO980216D0 (no) Telefonsentral
GB9518027D0 (en) Pharmacologically active compound
HRP960375B1 (en) Therapeutically active compounds
ID22149A (id) Gel antijamur dengan pelepasan senyawa aktif yang tinggi
NO981676L (no) FremgangsmÕte for montering av en bygningskonstruksjon
GB9526511D0 (en) Pharmaceutically active compounds
ZA963849B (en) Active compound combinations
KR970002905U (ko) 단소용 불대
SE9202000D0 (sv) A new therapeutically active compound
ITMI921865A1 (it) Glicerofosfoderivati farmacologicamente attivi
FR2735514B1 (fr) Serrure a pompe
KR970009874U (ko) 절수식 양변기
KR960031715U (ko) 간이용 텐트
GB9500427D0 (en) Pharmaceutically active compounds
GB9509942D0 (en) Pharmaceutically active compounds
GB9502670D0 (en) Pharmaceutically active compounds
GB9502541D0 (en) Pharmaceutically active compounds
GB9513686D0 (en) Pharmaceutically active compounds
GB9500099D0 (en) Pharmaceutically active compounds
GB9501122D0 (en) Pharmaceutically active compounds
GB9510461D0 (en) Pharmaceutically active compounds
GB9510406D0 (en) Pharmaceutically active compounds